NCT06221709 Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.
| NCT ID | NCT06221709 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Brasilia |
| Condition | Hip Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-02-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This will be a prospective, single-center, double-blinded, randomized study designed to compare the efficacy of the intraarticular injection of a corticosteroid and the Conventional Radiofrequency (CRF) of the anterior sensory branches to the hip in controlling pain and improving function related to hip osteoarthritis.
Eligibility Criteria
Inclusion Criteria: * Individuals ≥ 18 years of age, with symptomatic unilateral hip osteoarthritis, grades II and III according to the Kellgreen and Lawrance classification, hip pain for more than six months (medial, anterior, anterolateral, and/or lateral region) will be included. Exclusion Criteria: * Individuals with radiculopathy and ipsilateral irradiation, osteonecrosis of the femoral head, previous arthroplasty on the hip to be studied or surgical scar that could lead to changes in the anatomy of the hip, cases of high dislocation of the hip, pain exclusively in the posterior region, symptomatic ipsilateral knee osteoarthritis, intra-articular infiltration of corticosteroids or hyaluronic acid in the hip for less than six months, patients with neurological diseases, peripheral neuropathy or psychiatric diseases, use of a pacemaker or Prothrombin Activity Time (INR) \> 3.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06221709 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06221709 currently recruiting?
Yes, NCT06221709 is actively recruiting participants. Contact the research team at gilvanvaz@gmail.com for enrollment information.
Where is the NCT06221709 trial being conducted?
This trial is being conducted at Brasília, Brazil.
Who is sponsoring the NCT06221709 clinical trial?
NCT06221709 is sponsored by University of Brasilia. The trial plans to enroll 70 participants.